Correlation Between Amgen and Goldman Sachs

Can any of the company-specific risk be diversified away by investing in both Amgen and Goldman Sachs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and Goldman Sachs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amgen Inc and Goldman Sachs Capital, you can compare the effects of market volatilities on Amgen and Goldman Sachs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of Goldman Sachs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and Goldman Sachs.

Diversification Opportunities for Amgen and Goldman Sachs

-0.38

Correlation Coefficient

Amgen  Goldman Sachs

Very good diversification

The 3 months correlation between Amgen and Goldman is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and Goldman Sachs Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goldman Sachs Capital and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with Goldman Sachs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goldman Sachs Capital has no effect on the direction of Amgen i.e., Amgen and Goldman Sachs go up and down completely randomly.

Pair Corralation between Amgen and Goldman Sachs

Given the investment horizon of 90 days Amgen Inc is expected to generate 0.6 times more return on investment than Goldman Sachs. However, Amgen Inc is 1.66 times less risky than Goldman Sachs. It trades about 0.05 of its potential returns per unit of risk. Goldman Sachs Capital is currently generating about 0.02 per unit of risk. If you would invest  21,211  in Amgen Inc on October 22, 2024 and sell it today you would earn a total of  6,000  from holding Amgen Inc or generate 28.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	83.63%
Values	Daily Returns

Amgen Inc  vs.  Goldman Sachs Capital

Amgen Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Goldman Sachs Capital

Risk-Adjusted Performance

2 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Goldman Sachs Capital are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent fundamental drivers, Goldman Sachs is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Amgen and Goldman Sachs

The main advantage of trading using opposite Amgen and Goldman Sachs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, Goldman Sachs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goldman Sachs will offset losses from the drop in Goldman Sachs' long position.

The idea behind Amgen Inc and Goldman Sachs Capital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.